| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pha-739358 | aurora kinase a | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
1.27 | phase 2 | unknown |
| pha-739358 | aurora b messenger rna | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
1.06 | phase 2 | unknown |
| pha-739358 | aurora kinase b | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
1.06 | phase 2 | unknown |
| pha-739358 | aurora kinase c | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of prostate[MeSHID:D011471] |
4.63 | phase 2 | unknown |
| click here to return to the previous page | ||||||||